News summary

Healthtech: Europe’s 10 most-funded companies in H1 2026

Source: Tech.eu • Published: 05 Nov 2026, 12:00

Summarized by Masters of Longevity from Tech.eu.

Ten largest healthtech deals in H1 2026 totaled about €2.59 billion.

Healthtech: Europe’s 10 most-funded companies in H1 2026
Key Takeaways
  • Funding was concentrated in a few very large rounds.
  • AI-driven drug discovery and digital chronic care attracted investment.
  • Findings are observational and do not prove clinical benefit.
Read the full article at Tech.eu ↗

Continue exploring

Recommended MoL Picks

MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?